Inhibition of placental trophoblast fusion by guanylate-binding protein 5
Science Advances · 2025
DOI: 10.1126/sciadv.adt5388 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Veronika Krchlikova und 24 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Medical Virology, University Hospital Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Trophoblasts, Pregnancy Proteins, GTP-Binding Proteins, Placenta. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Syncytin-1 and Syncytin-2 are envelope glycoproteins encoded by human endogenous retroviruses that have been exapted for the fusion of cytotrophoblast cells into syncytiotrophoblasts during placental development. Pregnancy complications like preeclampsia are associated with altered expression of interferon-stimulated genes, including guanylate-binding protein 5 (GBP5). Here, we show that misdirected antiviral activity of GBP5 impairs processing and activation of Syncytin-1. In contrast, the proteolytic activation of Syncytin-2 is not affected by GBP5, and its fusogenic activity is only modestly reduced. Mechanistic analyses revealed that Syncytin-1 is mainly cleaved by the GBP5 target furin, whereas Syncytin-2 is also efficiently processed by the proprotein convertase subtilisin/kexin type 7 (PCSK7) and thus resistant to GBP5-mediated restriction. Mutational analyses mapped PCSK7 processing of Syncytin-2 to a leucine residue upstream of the polybasic cleavage site. In summary, we identified an innate immune mechanism that impairs the activity of a co-opted endogenous retroviral envelope protein during pregnancy and may potentially contribute to the pathogenesis of pregnancy disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute for Medical Virology, University Hospital Tübingen, Tübingen, Germany.
- Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.
- Institute of Molecular Genetics of the Czech Academy of Sciences, Prague, Czechia.
- College of Pharmacy, Chongqing Medical University, Chongqing, China.
- Department of Pathology, National Institute of Infectious Diseases, Tokyo, Japan.
- Charité-Universitätsmedizin Berlin, Institute of Virology, Berlin, Germany.
ORCID-Profile: Veronika Krchlikova, Elisabeth Braun, Krystof Stafl, Lukas Jech, Smitha Srinivasachar Badarinarayan, Rishikesh Lotke, Martin Travnicek, Paul Stark, Wei Wang, Kenzo Tokunaga, Oya Cingöz, Konstantin M J Sparrer, Madhuri S Salker, Frank Kirchhoff, Katerina Trejbalova, Daniel Sauter
Zitieren
APA
Krchlikova, V., Braun, E., Weiss, J., Stafl, K., Jech, L., Badarinarayan, S. S., Lotke, R., Travnicek, M., Baur, C., Stark, P., Haussmann, I., Lu, Y., Petersen, M., Cui, W., Wang, W., Fäger, B. M., Reisinger, H., Tokunaga, K., Cingöz, O., …, & Sauter, D. (2025). Inhibition of placental trophoblast fusion by guanylate-binding protein 5. Science Advances. https://doi.org/10.1126/sciadv.adt5388
Vancouver
Krchlikova V, Braun E, Weiss J, Stafl K, Jech L, Badarinarayan SS, et al. Inhibition of placental trophoblast fusion by guanylate-binding protein 5. Science Advances. 2025. doi:10.1126/sciadv.adt5388
BibTeX
@article{Krchlikova2025,
author = {Krchlikova, Veronika and Braun, Elisabeth and Weiss, Johanna and Stafl, Krystof and Jech, Lukas and Badarinarayan, Smitha Srinivasachar and Lotke, Rishikesh and Travnicek, Martin and Baur, Charlotte and Stark, Paul and Haussmann, Isabell and Lu, Yueshuang and Petersen, Moritz and Cui, Wen and Wang, Wei and Fäger, Bianca M and Reisinger, Hannah and Tokunaga, Kenzo and Cingöz, Oya and Sparrer, Konstantin M J and Salker, Madhuri S and Hejnar, Jiri and Kirchhoff, Frank and Trejbalova, Katerina and Sauter, Daniel},
title = {Inhibition of placental trophoblast fusion by guanylate-binding protein 5},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adt5388}
}
EUVIMED